Search Results

Prasad Pydi obtained his Ph.D. from the University of Manitoba – Canada, where he was introduced to G protein-coupled receptors (GPCRs) by Prof. His doctoral research focused on the structural and functional characterization of bitter taste receptors

University of Nottingham in 2006, where he is now Associate Professor, establishing a lab focused on G protein-coupled receptor kinetics, signaling, and trafficking and on using novel imaging techniques,

Molecular Medicine and Neuroscience at the University of Ottawa as a Postdoctoral Fellow to explore novel G protein-coupled receptor (GPCR) candidates that can be targeted pharmacologically to slow neurodegeneration

My research aims to understand the mechanisms and consequences cell communication via heterotrimeric G-proteins of established approaches (biochemistry, cell biology, genetics) and experimental systems (purified proteins Spain, Belgium, and a postdoctoral fellowship at UC San Diego, where he navigated a career focused on G protein-coupled receptors (GPCRs) while aiming to maintain broad scientific interests.

for Beta-arrestin signaling in the brain in vivo and has established its importance in D2 dopamine receptors These receptors belong to the super-family of G-protein coupled receptors (GPCR), the major molecular (e.g. lithium) used for bipolar disorder therapy target signaling mechanisms regulated by dopamine receptors The Beaulieu group is presently investigating how cell surface express proteins can act as allosteric These investigations have led to the identification of an RNA binding protein (FXR1P) involved in the

Philadelphia, PA, for his postdoctoral training in Jeff Benovic’s laboratory studying the regulation of G protein-coupled receptor trafficking and signaling.

As a young researcher fascinated by chemokine receptors, molecular pharmacology, drug discovery, and GPCR, an ecosystem designed to bring together stakeholders interested in using G-Protein Coupled Receptors Her work focused on chemokine receptors, members of the GPCR family that control cell movement in the

Slosky’s research is focused on understanding how neuropeptide G protein-coupled receptors (GPCRs) regulate motivated behavior and how these receptors can be targeted for therapeutic benefit. Marc G. Caron at Duke University. Dr. These ligands stimulate receptor β-arrestin recruitment without activating canonical G protein signaling Because BAMs engage less well-conserved allosteric sites and exert pathway-specific effects on receptor

His lab developed the GRK (G protein-coupled receptor kinase) family and discovered the beta-arrestins , proteins now understood as central mediators of receptor desensitization and G protein-independent Lefkowitz was awarded the Nobel Prize in Chemistry, shared with Brian Kobilka, for studies of G protein-coupled receptors. Functional analogies between the two systems had been recognized — both were G protein-coupled — but

University of Chicago and the University of Michigan shaped his scientific curiosity, particularly around G protein-coupled receptors (GPCRs) . His research centers on the beta-2 adrenergic receptor and GPR65 , a proton-sensing receptor with promising therapeutic potential of GPR65, especially in the context of cancer immunotherapy, and how understanding receptor My research has looked at the trafficking and signaling of adrenergic and proton-sensing receptors, with

proteins by G protein-coupled receptors (GPCRs). for agonist-mediated activation of G proteins. We continue to utilize these data to better understand the basis for receptor-G protein specificity and Again, our intention is to target specific receptor subtypes. changes in G protein structure.

mission is to discover and develop highly effective cancer therapeutics by targeting heteromers of G protein-coupled receptors (GPCR). At Medarex, she initiated and identified the lead mAb for the type I interferon-alpha receptor project

Explore GPCR lipid rafts, bitter taste receptor pharmacology, and data integration in this expert interview construction of an open-access GPCR-lipid raft database and reviews key findings from his research on D1 receptor When you’re mapping receptor localization and need to understand the mechanistic role of microdomains There, under Professor Mario Tiberi, he focused on G protein-coupled receptors and D1 receptor regulation—work that sparked his ongoing engagement with receptor signaling and microdomain biology.

GPCR webinars are live online scientific sessions focused on G protein-coupled receptor (GPCR) biology These webinars are ideal for: GPCR pharmacologists Medicinal chemists working on receptor targets Structural Topics frequently address: Receptor efficacy and bias Allosteric modulation PK/PD relationships Irreversible These webinars are designed for scientists with foundational knowledge in receptor pharmacology, signaling Topics may include: Receptor efficacy and operational models Allosteric modulators (PAMs and NAMs) Biased

Highlights of the week Structural insights into prolactin-releasing peptide receptor signaling and G-protein Protein-coupled Receptor Kinases and Arrestins - USA December 16 - 18, 2025 |Pharmacology 2025 - UK July ovarian fibroblasts Methods & Updates in GPCR Research Histamine-modulated wettability switching in G-protein-coupled Insights into GPCR Conformational Landscapes Covalent functionalization of G protein-coupled receptors signaling and G-protein coupling selectivity Decoding the structural basis of ligand recognition and

Terry Kenakin on detecting, quantifying, and applying receptor signaling bias in GPCR drug discovery. in GPCR drug discovery Beyond Potency: What Ligand-Dependent Signaling Reveals About Drug Candidates G protein-coupled receptors can signal through multiple intracellular pathways, and ligands do not necessarily This phenomenon, receptor signaling bias or functional selectivity, is now recognized as a meaningful they stabilize distinct receptor conformations.

Protein-Coupled Receptor Retreat held jointly with the Club des Récepteurs à Sept Domaines Transmembranaires University of North Carolina at Chapel Hill, unquestionably one of the pioneers involved in deciphering how receptor activity-modifying proteins or RAMPs regulate GPCR function, is confirmed as Plenary Speaker of the inaugural Marc G. Additionally, there will be a Marc G.

Novartis, and eventually founding in vitro pharmacology departments, Sokhom always stayed anchored to G protein-coupled receptors (GPCRs). There’s allosterism, receptor desensitization… it opened a whole new world.” He blends classical receptor pharmacology with biosensor technology, always adapting to new tools and About Sokhom Pin Sokhom Pin is a receptor pharmacologist with over 20 years of drug discovery research

GPCR, an ecosystem designed to bring together stakeholders interested in using G-Protein Coupled Receptors Her work focused on chemokine receptors, members of the GPCR family that control cell movement in the Her research centers on developing nanobody-ligand conjugates to target GPCRs, with a focus on receptors As a young researcher fascinated by chemokine receptors, molecular pharmacology, drug discovery, and I investigated the effect of lung cancer-related mutations in the GAIN domain of the Latrophilin 3 receptor

student visa was in the work, during which time I thoroughly reviewed the literature on the melanocortin receptor then undertook my first project where I demonstrated that MRAP2 regulates the signaling of multiple G protein-coupled receptors (GPCRs) through different structural regions. contributed to an In-vivo project that showed that MRAP2 regulates the growth hormone secretagogue receptor Cone was the first to clone the melanocortin receptors (the GPCRs that led to the discovery of MRAP2)

"I received my degree in biochemistry from Leipzig University (Germany) being already fascinated by G protein-coupled receptors (GPCRs) due to a stay as a scholarship student in the lab of Thue Schwartz They also discussed the challenges of studying metabolites and their receptors, the relationship between Challenges in Studying Metabolites and Receptors Claudia and Yamina discussed the challenges of studying metabolites and their receptors, particularly in relation to fermented foods.

Sep 20, 2022 — First contributor article published: Therapeutic validation of an orphan G protein‐coupled receptor by Inês Pinheiro .

for different families of GPCRs, including adenosine, dopamine, serotonin, cannabinoid and muscarinic receptors NanoBRET® competitive binding assay enables real-time quantification of ligand–receptor interactions By combining NanoLuc-tagged receptors with fluorescent tracers, this approach allows direct measurement GPCR, the global knowledge hub for G protein-coupled receptor (GPCR) research and education, is proud “These tools can dramatically improve how scientists measure ligand-receptor interactions, visualize

GPCR, an ecosystem designed to bring together stakeholders interested in using G-Protein Coupled Receptors Her work focused on chemokine receptors, members of the GPCR family that control cell movement in the San Francisco under the guidance of Professor Shaun Coughlin where she worked on the newly discovered protease-activated receptors (PARs) and the impact on vascular inflammation and cancer progression. Her laboratory is the recognized expert on protease-activated receptors, particularly PAR1, and over

A2B adenosine receptor-triggered intracellular calcium mobilization: Cell type-dependent involvement Protein-coupled Receptor Kinases and Arrestins NEW December 16 - 18, 2025 |Pharmacology 2025 July 12 Soft Substrate 🔎 GPCR KEYWORDS Class-A G protein-coupled receptors , Lophotrochozoa , echinoderms , , Calcium , G protein , GPCR , Gi , Gq , Gs , N-homocysteinylation , Adiposity , Fatty Acid Uptake , activity , purinergic receptor , substrate stiffness < Previous Next >

His journey highlights the transition from general drug development to a deep dive into G protein-coupled receptors. at the University of Michigan, Ben focuses on positive allosteric modulators (PAMs) targeting opioid receptors from the University of Minnesota in 2022, studying the pharmacokinetics and pharmacodynamics of NMDA receptor determining the mechanisms of action of a series of positive allosteric modulators of the mu-opioid receptor

the antibodies in their own labs and give structured feedback 📅 June 25, 2026 at 3:00:00 PM Details Receptor Terry Kenakin - UNC Chappel Hill | Terry's Pharmacology Corner Topics Covered The biological basis of receptor GPCR webinars are free, live online scientific sessions focused on G protein-coupled receptor biology Whether you're deep in receptor biology or evaluating assay tools, these sessions are built for you. Every session is grounded in receptor biology with a focus on what's practical and applicable.

Engineering Scientific Abstract G protein–coupled receptors (GPCRs) are among the most extensively studied protein families in pharmacology and drug discovery, yet many receptors remain poorly characterized These hybrid receptors enable researchers to probe receptor signaling, investigate G protein coupling Listeners gain insight into how computational protein design can accelerate receptor signaling research receptors with poorly understood receptors.

. << Back to podcast list Strategic Partner(s) Amynah Pradhan: The Delta Opioid Receptor and the Migraine For her, this line of work is also personal — the delta opioid receptor has been her scientific focus "Every person I know who studies G-protein coupled receptors will tell you — the antibodies suck. Paul Clarck , where she studied opioid receptors. Brigitte Kieffer , where she studied ligand-directed signaling at the delta-opioid receptor.

Over the course of my graduate work, I gained experience with structural mass spectrometry and protein crystallography, which shaped my interest in understanding how protein dynamics are linked to function There, I’ve been working towards understanding the molecular basis of G protein-coupled receptor desensitization machines and decided to work on memory proteins. He shared his experience working on a project involving receptor kinases and collaborating with other